Prospective, Randomized, Double-Blind Study of the Efficacy and Tolerability of the Extended-Release Formulations of Oxybutynin and Tolterodine for Overactive Bladder: Results of the OPERA Trial-Reference-Cited by-同舟云学术

Prospective, Randomized, Double-Blind Study of the Efficacy and Tolerability of the Extended-Release Formulations of Oxybutynin and Tolterodine for Overactive Bladder: Results of the OPERA Trial

Published:2003-06 Issue:6 Volume:78 Page:687-695
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Diokno Ananias C.,Appell Rodney A.,Sand Peter K.,Dmochowski Roger R.,Gburek Bernard M.,Klimberg Ira W.,Kell Sherron H.

Publisher

Elsevier BV

Subject

General Medicine

Reference22 articles.

1. Overactive bladder significantly affects quality of life;Abrams;Am J Manag Care,2000

2. Annual direct cost of urinary incontinence;Wilson;Obstet Gynecol,2001

3. Economic costs of urinary incontinence in 1995;Wagner;Urology,1998

4. Comorbidities associated with overactive bladder;Brown;Am J Manag Care,2000

5. Urinary incontinence and depression;Zorn;J Urol,1999

Cited by 260 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of solifenacin combined with biofeedback in children with overactive bladder;BMC Urology;2024-04-25

2. Comparative assessment of efficacy and safety of approved oral therapies for overactive bladder: a systematic review and network meta-analysis;International braz j urol;2023-10

3. Clinical Management of Polypharmacy in the Elderly Population;Osteopathic Family Physician;2023-08-31

4. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

5. Assessment of the continuity of treatment among patients using anticholinergic medication;Annals of Clinical and Analytical Medicine;2023-03-01